How metabolic disorders affect liver cirrhosis outcomes
Part of Hormones & metabolism clinical trials.
This study looks at how metabolic disorders (like diabetes or high cholesterol) affect the health of people with liver cirrhosis or advanced liver fibrosis. Your participation could help doctors better understand and manage these conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old
- You have liver scarring (cirrhosis) or advanced fibrosis, confirmed by imaging or a special scan (liver stiffness measurement)
- You have NOT had serious liver complications in the past year, such as bleeding in the stomach, moderate to severe belly swelling, or confusion from liver disease
- You have not had liver cancer or another cancer that cannot be cured
- You have not had a liver transplant
- You are not pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how nutrition affects the health of people with liver cirrhosis (scarred liver) and aims to build a tool to predict their outcomes. If you have cirrhosis, joining may help researchers find better ways to support your health.
This study is looking at how cirrhosis affects the heart (called cirrhotic cardiomyopathy). It aims to understand the connection between advanced liver disease and heart function, which may help improve care for people with cirrhosis.
This study aims to build a tool to predict how MASLD-related cirrhosis (fatty liver disease leading to liver scarring) will progress. It may help doctors and patients better understand the outlook and plan care.
This study looks at people with very advanced liver problems to better understand what happens in real life. It may help doctors improve care for advanced cirrhosis and certain liver cancers.
This study looks at people with fatty liver disease and common health issues like obesity, diabetes, high blood pressure, or abnormal cholesterol. It may help researchers understand how liver fat and heart/metabolism problems relate and how they affect health over time.
This study compares two treatments for liver scarring in people with overweight or related health issues. One group follows a special diet with restricted eating times, while the other takes a combination of two medications (naltrexone and bupropion). It aims to see which approach better improves liver fibrosis.
Hear when a new Compensated Advanced Chronic Liver Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.